Menstruation-Related Angina—The Wee Hours

Sandy Goyette, Tulika Mishra, Farah Raza, Zahra Naqvi, Sarah Khan, Abrar Khan, Pamphil Igman, M. S. Bhat
{"title":"Menstruation-Related Angina—The Wee Hours","authors":"Sandy Goyette, Tulika Mishra, Farah Raza, Zahra Naqvi, Sarah Khan, Abrar Khan, Pamphil Igman, M. S. Bhat","doi":"10.1055/s-0044-1782602","DOIUrl":null,"url":null,"abstract":"Literature reveals two kinds of menstruation-related anginas—cardiac syndrome X (CSX) and catamenial angina. CSX generally occurs in perimenopausal or postmenopausal women; catamenial angina affects females from puberty to menopause with existing/preexisting or predisposed to coronary artery disease. CSX involves recurring anginal-type retrosternal chest pains during exercise or rest with no significant findings on angiogram. Catamenial angina is menstruation-associated recurrent nonexertional left-sided chest pain alongside diaphoresis, hot flushes, and persistent lethargy. Pathophysiology of both anginas revolve around decreased levels of estrogen. Estrogen is known to act via genomic and nongenomic pathways on cardiomyocytes, endothelial cells, and smooth muscle cells to exert its cardioprotective effect. These cardioprotective effects could be lost during the postovulation phase and at the end of menstruation as well as during perimenopause or menopause owing to the decreased levels of estrogen. Evaluation should begin with a history and physical examination and focus on noninvasive tests such as exercise tolerance test, electrocardiogram, and echocardiogram. Reducing symptoms that cause discomfort and improving quality of life should be the main goal in management. Nitrates along with β blockers and analgesics for pain are the main pharmacologic modalities. Exercise training, smoking cessation, weight loss, and dietary changes are nonpharmacological modalities. Proper awareness and effective communication with patients or caregivers can lead to early diagnosis and treatment initiation.","PeriodicalId":506654,"journal":{"name":"International Journal of Angiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Angiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0044-1782602","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Literature reveals two kinds of menstruation-related anginas—cardiac syndrome X (CSX) and catamenial angina. CSX generally occurs in perimenopausal or postmenopausal women; catamenial angina affects females from puberty to menopause with existing/preexisting or predisposed to coronary artery disease. CSX involves recurring anginal-type retrosternal chest pains during exercise or rest with no significant findings on angiogram. Catamenial angina is menstruation-associated recurrent nonexertional left-sided chest pain alongside diaphoresis, hot flushes, and persistent lethargy. Pathophysiology of both anginas revolve around decreased levels of estrogen. Estrogen is known to act via genomic and nongenomic pathways on cardiomyocytes, endothelial cells, and smooth muscle cells to exert its cardioprotective effect. These cardioprotective effects could be lost during the postovulation phase and at the end of menstruation as well as during perimenopause or menopause owing to the decreased levels of estrogen. Evaluation should begin with a history and physical examination and focus on noninvasive tests such as exercise tolerance test, electrocardiogram, and echocardiogram. Reducing symptoms that cause discomfort and improving quality of life should be the main goal in management. Nitrates along with β blockers and analgesics for pain are the main pharmacologic modalities. Exercise training, smoking cessation, weight loss, and dietary changes are nonpharmacological modalities. Proper awareness and effective communication with patients or caregivers can lead to early diagnosis and treatment initiation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
月经相关心绞痛--凌晨时分
文献揭示了两种与月经有关的心绞痛--心脏综合征 X(CSX)和心肌缺血性心绞痛。CSX 通常发生在围绝经期或绝经后的女性身上;心绞痛发生在青春期至绝经期的女性身上,这些女性存在/已有或易患冠状动脉疾病。CSX是指在运动或休息时反复出现心绞痛型胸骨后胸痛,但血管造影无明显发现。卡他性心绞痛是与月经有关的反复发作的非劳累性左侧胸痛,同时伴有心悸、潮热和持续嗜睡。这两种心绞痛的病理生理学都与雌激素水平下降有关。众所周知,雌激素可通过基因组和非基因组途径作用于心肌细胞、内皮细胞和平滑肌细胞,从而发挥保护心脏的作用。由于雌激素水平下降,这些心脏保护作用可能会在排卵后、月经结束、围绝经期或更年期消失。评估应从病史和体格检查开始,并侧重于无创检查,如运动耐量测试、心电图和超声心动图。减轻引起不适的症状和提高生活质量应是治疗的主要目标。硝酸盐类药物、β受体阻滞剂和止痛剂是主要的药物治疗方法。运动训练、戒烟、减肥和改变饮食习惯则是非药物疗法。正确的认识以及与患者或护理人员的有效沟通可以帮助患者及早诊断并开始治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Major Delay in Door-to-Ballon Time for Primary Percutaneous Coronary Intervention is Not Related to Interventional Cardiologist's Late Arrival Atherogenic Effect of Homocysteine, a Biomarker of Inflammation and Its Treatment Venous Thromboembolism: Current Insights and Future Directions Association of ET1 and APE1 Genes Polymorphism with Coronary Artery Disease Comparative Efficacy of Hypertension Management Strategies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1